WESTBROOK, Maine, Jan. 4, 2017 /PRNewswire/ -- IDEXX Laboratories,
Inc. (NASDAQ: IDXX) today announced that it has been named to the
S&P 500® and will join after close of trading today.
The world-renowned index includes 500 of the top companies in
leading industries of the U.S. economy.
"It's an incredible honor for IDEXX to be included in the
S&P 500, alongside many of the world's most respected
companies," said Jonathan Ayers,
Chairman and Chief Executive Officer of IDEXX Laboratories. "This
recognition is a testament to our strong growth since our founding
in Portland, Maine, some 34 years
ago. IDEXX is proud to add a company focused on pet healthcare
technology to the S&P 500, and I am deeply grateful to all of
our customers, employees, and shareholders who have contributed to
this achievement."
Created in 1957, the S&P 500 is the benchmark for over
$7.8 trillion in equity investments
and index assets comprise $2.2
trillion of this total. The S&P 500 is widely regarded
as the best single gauge of large-cap U.S. equities and captures
approximately 80% coverage of available market capitalization.
For more IDEXX corporate information, visit:
www.idexx.com/investors
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a
leader in pet healthcare innovation, serving practicing
veterinarians around the world with a broad range of diagnostic and
information technology-based products and services. IDEXX products
enhance the ability of veterinarians to provide advanced medical
care, improve staff efficiency, and build more economically
successful practices. IDEXX is also a worldwide leader in providing
livestock and poultry diagnostic tests and tests for the quality
and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,000 people
and offers products to customers in over 175 countries.
Contact:
Investor Relations:
Kerry
Bennett
1-207-556-8155
Media:
Elizabeth Hunt
1-207-556-4650
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/idexx-laboratories-to-join-sp-500-index-300385477.html
SOURCE IDEXX Laboratories, Inc.